RSS-Feed abonnieren
PDF herunterladen
DOI: 10.4103/2278-330X.149942
Cancer related fatigue: A ubiquitous problem yet so under reported, under recognized and under treated
Autor*innen
Source of Support: Nill.
Abstract
Background: Cancer related fatigue (CRF) is a problem that is highly under reported, under recognized and thus, under treated. About 80% of patients receiving chemotherapy/radiotherapy experience CRF, making it the most common side effect of cancer treatment. Functional assessment of chronic illness therapy fatigue (FACIT-F) version-4 is a 13 item questionnaire that has been used to measure the level of fatigue of cancer patients during their daily activities over the past 7 days. Materials and Methods: 92 patients of age 18 years and above attending the oncology Out Patient Department (OPD) of a regional cancer center were recruited in this study and were given FACIT-F questionnaire. The relevant sociodemographic parameters were obtained from the medical records of the patients. The internal consistency of the 13 items was measured using the Cronbach′s alpha. Results: The Cronbach alpha coefficient for FACIT-F scale in our study was found to be 0.74. Kendall′s coefficient of concordance was estimated to be 0.080. The correlation between Eastern Cooperative Oncology Group (ECOG) performance status and mean score of FACIT-F was studied, Pearson correlation coefficient was estimated to be 0.271 (P = 0.009). Conclusions: FACIT-F is a brief, simple, easy to administer and patient friendly tool to measure the fatigue in last 7 days. CRF should be given adequate attention from the beginning of the treatment to improve the quality of life of cancer patients.
Publikationsverlauf
Artikel online veröffentlicht:
31. Dezember 2020
© 2015. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. Version 1. 2014 ed. National Comprehensive Cancer Network. Available from: http://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf [Accessed 2014 Feb 10].
- 2 Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 1998;12:369-77.
- 3 Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: Properties, applications, and interpretation. Health Qual Life Outcomes 2003;1:1-7.
- 4 Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34 (3 Suppl 2):4-12.
- 5 Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, et al. Symptom prevalence, characteristics, and distress in a cancer population. Qual Life Res 1994;3:183-9.
- 6 Ventafridda V, De Conno F, Ripamonti C, Gamba A, Tamburini M. Quality-of-life assessment during a palliative care program. Ann Oncol 1990;1:415-20.
- 7 Dunlop GM. A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far-advanced cancer: Student paper. Palliat Med 1989;4:37-43.
- 8 Joly F, Henry-Amar M, Arveux P, Reman O, Tanguy A, Peny AM, et al. Late psychosocial sequelae in Hodgkin′s disease survivors: A French population-based case-control study. J Clin Oncol 1996;14:2444-53.
- 9 Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjödén PO. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 1991;27:1075-81.
- 10 Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, et al. Factors correlated with fatigue in disease-free breast cancer patients: Application of the Cancer Fatigue Scale. Support Care Cancer 2000;8:215-22.
- 11 Portenoy RK. Cancer-related fatigue: An immense problem. Oncologist 2000;5:350-2.
- 12 Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, et al. Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 1998;279:1877-82.
- 13 Pargeon KL, Hailey BJ. Barriers to effective cancer pain management: A review of the literature. J Pain Symptom Manage 1999;18:358-68.
- 14 Karthikeyan G, Jumnani D, Prabhu R, Manoor UK, Supe SS. Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of Life: A cross-sectional study. Indian J Palliat Care 2012;18:165-75.
- 15 Schmidt ME, Chang-Claude J, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K. Fatigue and quality of life in breast cancer survivors: Temporal courses and long-term pattern. J Cancer Surviv 2012;6:11-9.
- 16 Stone P, Richards M, A′Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 2000;11:561-7.